Sarepta Therapeutics, Inc. — Director's Dealing 2011

Jul 29, 2011

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-07-24

Reporting Person: MILE MELINDA G (Controller and PAO)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$1	2019-05-18	Common Stock (13333)		Direct
Stock Option (right to buy)	$1.49	2020-02-08	Common Stock (11666)		Direct

Footnotes

F1: 13,333 shares underlying the option will vest on 5/18/2012.

F2: 5,833 shares underlying the option will vest on 2/8/2012 and the remaining 5,833 shares underlying the option will vest on 2/8/2013.